These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24758094)

  • 1. [Chinese materia medica monomers and components research progress on treating Alzheimer's disease by targeting gamma-secretase].
    Liu MX; Liu JG; Li H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Mar; 34(3):376-9. PubMed ID: 24758094
    [No Abstract]   [Full Text] [Related]  

  • 2. [Research progress on standards of commodity classes of Chinese materia medica and discussion on several key problems].
    Yang G; Zeng Y; Guo LP; Huang LQ; Jin Y; Zheng YG; Wang YY
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1733-8. PubMed ID: 25095394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of Alzheimer's disease using Chinese medicinal plants: from disease models to potential clinical applications.
    Su Y; Wang Q; Wang C; Chan K; Sun Y; Kuang H
    J Ethnopharmacol; 2014 Mar; 152(3):403-23. PubMed ID: 24412377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress of study on treatment of Alzheimer's disease with active ingredients of Chinese herbal medicines].
    Zhao JK; Wang DS
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Feb; 28(2):177-81. PubMed ID: 18386587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. γ-Secretase as a target for Alzheimer's disease.
    Wolfe MS
    Adv Pharmacol; 2012; 64():127-53. PubMed ID: 22840746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interventional effects of traditional Chinese medicine on Alzheimer disease].
    Li H
    Zhongguo Zhong Yao Za Zhi; 2008 Nov; 33(21):2449-53. PubMed ID: 19149245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are γ-secretase inhibitors detrimental for Alzheimer's disease patients?
    Ross JS; Imbimbo BP
    J Alzheimers Dis; 2010; 22(2):401-4. PubMed ID: 21149978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of the results of syndrome in clinical trials of dementia treated by Chinese herbal medicine].
    Ni JN; Shi J; Tian JZ; Liu BL; Liu JP; Liu TH; Xu SQ; Cui GP; Wang YY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Mar; 33(3):404-7. PubMed ID: 23713260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
    Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
    J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.
    D'Onofrio G; Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Paroni G; Cascavilla L; Seripa D; Pilotto A
    Expert Opin Drug Discov; 2012 Jan; 7(1):19-37. PubMed ID: 22468891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretase inhibitors and modulators for Alzheimer's disease treatment.
    Tomita T
    Expert Rev Neurother; 2009 May; 9(5):661-79. PubMed ID: 19402777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.
    Kreft AF; Martone R; Porte A
    J Med Chem; 2009 Oct; 52(20):6169-88. PubMed ID: 19694467
    [No Abstract]   [Full Text] [Related]  

  • 13. [Progress and thinking on the herb-pairs of Chinese medicine].
    Yang HZ; Gong YP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Feb; 30(2):218-20. PubMed ID: 20462057
    [No Abstract]   [Full Text] [Related]  

  • 14. Learning by failing: ideas and concepts to tackle γ-secretases in Alzheimer's disease and beyond.
    De Strooper B; Chávez Gutiérrez L
    Annu Rev Pharmacol Toxicol; 2015; 55():419-37. PubMed ID: 25292430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. gamma-secretases: from cell biology to therapeutic strategies.
    Bergmans BA; De Strooper B
    Lancet Neurol; 2010 Feb; 9(2):215-26. PubMed ID: 20129170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological examination of TCM should be evidence based.
    Hawkes D; Benhamu J
    Trends Pharmacol Sci; 2014 Mar; 35(3):111-2. PubMed ID: 24559937
    [No Abstract]   [Full Text] [Related]  

  • 17. A survey of TCM treatment for Alzheimer's disease.
    Zhu W; Hu H
    J Tradit Chin Med; 2007 Sep; 27(3):226-32. PubMed ID: 17955663
    [No Abstract]   [Full Text] [Related]  

  • 18. Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease.
    Wolfe MS; De Los Angeles J; Miller DD; Xia W; Selkoe DJ
    Biochemistry; 1999 Aug; 38(35):11223-30. PubMed ID: 10471271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. γ-Secretase component presenilin is important for microglia β-amyloid clearance.
    Farfara D; Trudler D; Segev-Amzaleg N; Galron R; Stein R; Frenkel D
    Ann Neurol; 2011 Jan; 69(1):170-80. PubMed ID: 21280087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. γ-Secretase modulators as potential disease modifying anti-Alzheimer's drugs.
    Oehlrich D; Berthelot DJ; Gijsen HJ
    J Med Chem; 2011 Feb; 54(3):669-98. PubMed ID: 21141968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.